Healthcare - Biotechnology - NASDAQ - US
$ 3.8
-11.6 %
$ 122 M
Market Cap
-2.24
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--20.24%
Net Income
Estimate
43.83%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Candel Therapeutics, Inc.
CADL has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CADL
EBIT FORECAST
EBIT Forecast Chart CADL
NET INCOME FORECAST
Net Income Chart CADL